Page last updated: 2024-11-05

trifluoperazine and Myocardial Ischemia

trifluoperazine has been researched along with Myocardial Ischemia in 2 studies

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luciani, GB1
D'Agnolo, A1
Mazzucco, A1
Gallucci, V1
Salviati, G1
Kimura, Y1
Engelman, RM1
Rousou, J1
Flack, J1
Iyengar, J1
Das, DK1

Other Studies

2 other studies available for trifluoperazine and Myocardial Ischemia

ArticleYear
Effects of ischemia on sarcoplasmic reticulum and contractile myofilament activity in human myocardium.
    The American journal of physiology, 1993, Volume: 265, Issue:4 Pt 2

    Topics: Actin Cytoskeleton; Adult; Caffeine; Calcium; Calcium Channels; Electrophoresis; Female; Heart; Huma

1993
Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition.
    Heart and vessels, 1992, Volume: 7, Issue:4

    Topics: Animals; Calcium Channels; Calmodulin-Binding Proteins; Coronary Circulation; Creatine Kinase; Dilti

1992